261 related articles for article (PubMed ID: 28419517)
61. Limitations and practical procedure in BclII-Ig heavy chain gene rearrangement real-time quantitative polymerase chain reaction.
Dessars B; Heimann P; Swillens S; El Housni H
J Mol Diagn; 2006 Feb; 8(1):133-6. PubMed ID: 16436645
[TBL] [Abstract][Full Text] [Related]
62. Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma.
Hamamoto Y; Kukita Y; Kitamura M; Kurashige M; Masaie H; Fuji S; Ishikawa J; Honma K; Wakasa T; Hanamoto H; Hirokawa M; Suzuki A; Morii E; Nakatsuka SI
Histopathology; 2021 Oct; 79(4):521-532. PubMed ID: 33829512
[TBL] [Abstract][Full Text] [Related]
63. [BCL-2/IgH and IgH gene rearrangements in bone marrow mononuclear cells of patients with non-Hodgkin's lymphoma].
Zhang XH; Liang Y; Wang GJ; Ruan EB; Fu R; Qu W; Liu H; Guan J; Song J; Wang HQ; Wu YH; Xing LM; Wang XM; Wang J; Li LJ; Shao ZH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):379-84. PubMed ID: 21518492
[TBL] [Abstract][Full Text] [Related]
64. Absence of somatic hypermutation in the open reading frame of the bcl-2 gene participating in the t(14;18) chromosomal translocation in follicular lymphoma.
Kyriazopoulos P; Stamatopoulos K; Kosmas C; Belessi C; Stavroyianni N; Yataganas X; Papadaki T
Leuk Lymphoma; 2002 Dec; 43(12):2391-3. PubMed ID: 12613529
[TBL] [Abstract][Full Text] [Related]
65. [Detection of bcl-2/IgH fusion gene in lymphoma by real-time polymerase chain reaction and its clinical significance].
Zhang XM; Xu M; Liu H; Li HM; Li YT; He ZC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):368-72. PubMed ID: 19379568
[TBL] [Abstract][Full Text] [Related]
66. Quantification of DAPK1 promoter methylation in bone marrow and peripheral blood as a follicular lymphoma biomarker.
Giachelia M; Bozzoli V; D'Alò F; Tisi MC; Massini G; Maiolo E; Guidi F; Cupelli E; Martini M; Larocca LM; Voso MT; Leone G; Hohaus S
J Mol Diagn; 2014 Jul; 16(4):467-76. PubMed ID: 24814955
[TBL] [Abstract][Full Text] [Related]
67. Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma.
Berinstein NL; Reis MD; Ngan BY; Sawka CA; Jamal HH; Kuzniar B
J Clin Oncol; 1993 Jul; 11(7):1344-52. PubMed ID: 8315432
[TBL] [Abstract][Full Text] [Related]
68. [Bcl-2/JH gene re-arrangement determined by PCR as a means to detect minimal residual disease in malignant lymphomas].
Xiang Z; Chen Y; Li C
Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):290-2. PubMed ID: 10920987
[TBL] [Abstract][Full Text] [Related]
69. Efficacy of screening the intermediate cluster region of the bcl2 gene in follicular lymphomas by PCR.
Batstone PJ; Goodlad JR
J Clin Pathol; 2005 Jan; 58(1):81-2. PubMed ID: 15623489
[TBL] [Abstract][Full Text] [Related]
70. High frequency of t(14;18)-translocation breakpoints outside of major breakpoint and minor cluster regions in follicular lymphomas: improved polymerase chain reaction protocols for their detection.
Albinger-Hegyi A; Hochreutener B; Abdou MT; Hegyi I; Dours-Zimmermann MT; Kurrer MO; Heitz PU; Zimmermann DR
Am J Pathol; 2002 Mar; 160(3):823-32. PubMed ID: 11891181
[TBL] [Abstract][Full Text] [Related]
71. Minimal Residual Disease Analysis by Monitoring Immunoglobulin and T-Cell Receptor Gene Rearrangements by Quantitative PCR and Droplet Digital PCR.
Starza ID; Eckert C; Drandi D; Cazzaniga G;
Methods Mol Biol; 2022; 2453():79-89. PubMed ID: 35622321
[TBL] [Abstract][Full Text] [Related]
72. The implication of follicular lymphoma patients receiving allogeneic stem cell transplantation from donors carrying t(14;18)-positive cells.
McGregor DK; Keever-Taylor CA; Bredeson C; Schur B; Vesole DH; Logan B; Chang CC
Bone Marrow Transplant; 2005 Jun; 35(11):1049-54. PubMed ID: 15821762
[TBL] [Abstract][Full Text] [Related]
73. Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia-positive acute lymphoblastic leukaemia.
Ansuinelli M; Della Starza I; Lauretti A; Elia L; Siravo V; Messina M; De Novi LA; Taherinasab A; Canichella M; Guarini A; Foà R; Chiaretti S
Hematol Oncol; 2021 Dec; 39(5):680-686. PubMed ID: 34402088
[TBL] [Abstract][Full Text] [Related]
74. High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up.
Apostolidis J; Gupta RK; Grenzelias D; Johnson PW; Pappa VI; Summers KE; Salam A; Adams K; Norton AJ; Amess JA; Matthews J; Bradburn M; Lister TA; Rohatiner AZ
J Clin Oncol; 2000 Feb; 18(3):527-36. PubMed ID: 10653868
[TBL] [Abstract][Full Text] [Related]
75. FISH is better than BIOMED-2 PCR to detect IgH/BCL2 translocation in follicular lymphoma at diagnosis using paraffin-embedded tissue sections.
Espinet B; Bellosillo B; Melero C; Vela MC; Pedro C; Salido M; Pijuan L; Florensa L; Besses C; Serrano S; Solé F
Leuk Res; 2008 May; 32(5):737-42. PubMed ID: 17964648
[TBL] [Abstract][Full Text] [Related]
76. Association of clinical status of follicular lymphoma patients after autologous stem cell transplant and quantitative assessment of lymphoma in blood and bone marrow as measured by SYBR Green I polymerase chain reaction.
Pennell N; Woods A; Reis M; Buckstein R; Spaner D; Imrie K; Hewitt K; Boudreau A; Seth A; Berinstein NL
J Mol Diagn; 2006 Feb; 8(1):40-50. PubMed ID: 16436633
[TBL] [Abstract][Full Text] [Related]
77. Bone marrow minimal disseminated disease (MDD) and minimal residual disease (MRD) in childhood T-cell lymphoblastic lymphoma stage III, detected by flow cytometry (FC) and real-time quantitative polymerase chain reaction (RQ-PCR).
Stark B; Avigad S; Luria D; Manor S; Reshef-Ronen T; Avrahami G; Yaniv I
Pediatr Blood Cancer; 2009 Jan; 52(1):20-5. PubMed ID: 19006253
[TBL] [Abstract][Full Text] [Related]
78. Quantitative PCR analysis for Bcl-2/IgH in a phase III study of Yttrium-90 Ibritumomab Tiuxetan as consolidation of first remission in patients with follicular lymphoma.
Goff L; Summers K; Iqbal S; Kuhlmann J; Kunz M; Louton T; Hagenbeek A; Morschhauser F; Putz B; Lister A; Rohatiner A
J Clin Oncol; 2009 Dec; 27(36):6094-100. PubMed ID: 19858392
[TBL] [Abstract][Full Text] [Related]
79. Cyclin D1 mRNA as a molecular marker for minimal residual disease monitoring in patients with mantle cell lymphoma.
Lokvenc M; Kalinova M; Forsterova K; Klener P; Trneny M; Fronkova E; Kodet R
Ann Hematol; 2018 Mar; 97(3):467-474. PubMed ID: 29273915
[TBL] [Abstract][Full Text] [Related]
80. [Monitoring IgH levels in patients with B-cell malignancy by real-time quantitative PCR after hematopoietic stem cell transplantation and its significance].
Yu Z; Wang YF; Li ZJ; Zhou Z; Xu SC; Qiu LG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1236-9. PubMed ID: 18088474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
